Molecular classification may improve method physicians use to diagnose, treat gliomas

The molecular makeup of brain tumors can be used to sort patients with gliomas into five categories, each with different clinical features and outcomes, researchers have shown. The finding could change the methods that physicians rely on to determine prognosis and treatment options. Previously, they relied on how patients' tumors look under the microscope.